A new study adds to conflicting data on the use of ovarian suppression during chemotherapy in premenopausal women with breast cancer. Medscape Medical News
An intervention targeting hepatitis B virus resulted in a 96% screening rate, compared with 2% for a group with a more general intervention. Medscape Medical News